ST
OREX

Spot Trading’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Spot Trading’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,100
Closed -$157K – 4533
2015
Q4 		$157K Sell
9,100
-8,570
-49% -$204K ﹤0.01% 2600
2015
Q3 		$373K Buy
17,670
+8,910
+102% +$305K ﹤0.01% 2254
2015
Q2 		$434K Sell
8,760
-28,660
-77% -$1.71M ﹤0.01% 2213
2015
Q1 		$2.93M Buy
37,420
+17,320
+86% +$1.07M 0.03% 857
2014
Q4 		$1.22M Sell
20,100
-9,000
-31% -$452K 0.01% 1757
2014
Q3 		$1.24M Buy
29,100
+26,440
+994% +$1.42M 0.01% 1929
2014
Q2 		$164K Sell
2,660
-1,070
-29% -$62.2K ﹤0.01% 3460
2014
Q1 		$242K Buy
3,730
+1,080
+41% +$73K ﹤0.01% 3029
2013
Q4 		$149K Buy
+2,650
New +$149K ﹤0.01% 3156

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spot Trading's OREX Position: Q1 2016 in Review

Spot Trading sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2016, closing a stake of 5 shares.

Spot Trading first reported a position in OREX in Q3 2013 and held it in 8 quarters. The position peaked at $1.78M in Q1 2015. 104 funds tracked by Wall St. Rank hold OREX as of Q1 2016.

  • Spot Trading reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 5 Orexigen Therapeutics, Inc. shares in Q1 2016.
  • Spot Trading first reported a position in Orexigen Therapeutics, Inc. in Q3 2013 and held it in 8 quarters.
  • Spot Trading's Orexigen Therapeutics, Inc. position peaked at $1.78M in Q1 2015.
  • 104 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.